Manufacturing Miracles

LATEST NEWS

IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases

“We believe that AAV gene therapy is the future of drug development for orphan inherited retinal diseases,” stated Keith Westby, Chief Operating Officer of IVERIC bio. “When building a gene therapy franchise the selection of an experienced manufacturer is a critical component. We believe Paragon’s specialized expertise in AAV vector manufacturing and the addition of their new world-class commercial-scale facility will positively impact the advancement of our gene therapy pipeline. We look forward to collaborating closely with the Paragon team.”

MEDIA & PRESS CONTACT 

Colleen Floreck, Senior Director, Marketing & Communications

+1 443-262-3246 | cfloreck@paragonbioservices.com

JOIN THE CONVERSATION

Follow us on social media!

EVENTS

Come meet us!

World Vaccine Congress Washington

Bioprocessing Summit

August 12 – 16

Seaport World Trade Center, Boston, MA

Booth 134

We would be delighted to meet you in person during the show. Contact us to schedule a time to discuss your needs!

Paragon Bioservices will be attending and or be exhibiting at the following events.

World Vaccine Congress Washington

Phacilitate Leaders Europe

September 17 – 18

Royal Lancaster, London

Paragon Bioservices will be attending and or be exhibiting at the following events.

World Vaccine Congress Washington

Cell & Gene Meeting on the Mesa

October 2 – 4

Carlsbad, CA